141 related articles for article (PubMed ID: 20123919)
1. The use of depot medications in the treatment of schizophrenia.
Davis JM
Am J Psychiatry; 2010 Feb; 167(2):125-6. PubMed ID: 20123919
[No Abstract] [Full Text] [Related]
2. Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.
Kirson NY; Weiden PJ; Yermakov S; Huang W; Samuelson T; Offord SJ; Greenberg PE; Wong BJ
J Clin Psychiatry; 2013 Jun; 74(6):568-75. PubMed ID: 23842008
[TBL] [Abstract][Full Text] [Related]
3. Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medications.
Novick D; Haro JM; Bertsch J; Anand H; Jemiai N; Haddad PM
Int Clin Psychopharmacol; 2012 Sep; 27(5):275-82. PubMed ID: 22699789
[TBL] [Abstract][Full Text] [Related]
4. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
Möller HJ; Kissling W
Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
[No Abstract] [Full Text] [Related]
5. Oral depot antipsychotic drugs: time for a paradigm shift?
Nandhra HS; Sule A
J Ment Health; 2015 Aug; 24(4):181-2. PubMed ID: 25675262
[No Abstract] [Full Text] [Related]
6. [The significance of depot medication in the long-term-treatment of schizophrenia].
Kühn KU; Wiedemann K; Hellweg R; Möller HJ
Fortschr Neurol Psychiatr; 2014 Oct; 82(10):557-65. PubMed ID: 25299626
[TBL] [Abstract][Full Text] [Related]
7. Treatment adherence in schizophrenia and schizoaffective disorder.
Goff DC; Hill M; Freudenreich O
J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
[TBL] [Abstract][Full Text] [Related]
8. Longterm maintenance therapy with depot haloperidol in schizophrenia.
Zbytovský J
Homeost Health Dis; 1991; 33(5-6):287. PubMed ID: 18265499
[No Abstract] [Full Text] [Related]
9. Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: a nationwide study in Hungary.
Bitter I; Katona L; Zámbori J; Takács P; Fehér L; Diels J; Bacskai M; Lang Z; Gyáni G; Czobor P
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1383-90. PubMed ID: 23477752
[TBL] [Abstract][Full Text] [Related]
10. Psychopharmacological treatment of schizophrenia.
Lehmann HE
Schizophr Bull; 1975; (13):27-45. PubMed ID: 1851
[No Abstract] [Full Text] [Related]
11. Long-acting injectable antipsychotics in early psychosis: a literature review.
Emsley R; Chiliza B; Asmal L; Mashile M; Fusar-Poli P
Early Interv Psychiatry; 2013 Aug; 7(3):247-54. PubMed ID: 23342964
[TBL] [Abstract][Full Text] [Related]
12. Oral versus depot medication in schizophrenia.
Johnson DA
Acta Psychiatr Scand Suppl; 1981; 291():56-64. PubMed ID: 6113735
[TBL] [Abstract][Full Text] [Related]
13. Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication.
Citrome L
Int J Clin Pract; 2010 Jan; 64(2):216-39. PubMed ID: 19886879
[TBL] [Abstract][Full Text] [Related]
14. Switching From the Oral to the Depot Formulation of a Medication: Clinically Relevant Pharmacokinetic Concepts and Considerations.
Preskorn SH
J Psychiatr Pract; 2017 May; 23(3):200-209. PubMed ID: 28492458
[TBL] [Abstract][Full Text] [Related]
15. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
Agid O; Foussias G; Remington G
Expert Opin Pharmacother; 2010 Oct; 11(14):2301-17. PubMed ID: 20586707
[TBL] [Abstract][Full Text] [Related]
16. Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.
Citrome L
CNS Spectr; 2012 Nov; 17 Suppl 1():1-9. PubMed ID: 23448847
[TBL] [Abstract][Full Text] [Related]
17. Relapse and rehospitalization: comparing oral and depot antipsychotics.
Schooler NR
J Clin Psychiatry; 2003; 64 Suppl 16():14-7. PubMed ID: 14680414
[TBL] [Abstract][Full Text] [Related]
18. Depot neuroleptic therapy: an underutilized treatment option.
Glazer WM; Kane JM
J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.
Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E
Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986
[TBL] [Abstract][Full Text] [Related]
20. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Dencker SJ
J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
